This week's highlights: Kudos to our partner, GPCR Therapeutics, for partnering with Bridge Biotherapeutics meta-dynamics/FMO3 approach Industry News GPCR Therapeutics Announces Out-Licensing Agreement with Bridge Biotherapeutics in Idiopathic Pulmonary Fibrosis Former execs from Pfizer obesity drug program have

November 2021 Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID offering of high-quality synthetic DNA using its silicon platform, today announced it has launched Revelar Biotherapeutics

April 2022 Trevena Receives up to $40M in OLINVYK ex-US Royalty-Based Financing from R-Bridge Healthcare disorders, today announced that the Company entered into a royalty-based financing with an affiliate of R-Bridge Healthcare Fund (the R-Bridge Financing)."

His current work is mainly focused on screening and assay development to bridge the gap between in vitro

His current work is mainly focused on screening and assay development to bridge the gap between in vitro

Translational validation is important to validate findings obtained from experimental models research and bridge